|
|
||||||||||
|
Click on image to view larger version.
Figure 11 Cumulative rate of recurrent myocardial infarction or death from cardiac causes among statin-treated patients according to achieved levels of both low-density lipoprotein (LDL) cholesterol and high-sensitivity C-reactive protein (CRP) in the TIMI 22 trial. Adapted with permission from Ridker et al. (106). TIMI = Thrombolysis In Myocardial Infarction.
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |